Postural hypotension and dizziness in a general aged population: A four-year follow-up of the Helsinki Aging Study

被引:119
作者
Tilvis, RS [1 ]
Hakala, SM [1 ]
Valvanne, J [1 ]
Erkinjuntti, T [1 ]
机构
[1] HELSINKI UNIV,DEPT NEUROL,MEMORY RES UNIT,FIN-00290 HELSINKI,FINLAND
关键词
D O I
10.1111/j.1532-5415.1996.tb03738.x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
OBJECTIVE: To evaluate the frequency, risk factors, and prognostic significances of postural hypotension (PH) and dizziness on postural testing (DPT). DESIGN: A prospective cohort study. SETTING: General community, The Helsinki (Finland) Aging Study. SUBJECTS: Persons of three age cohorts (75, 80, and 85 years, n = 569) were chosen randomly and followed for 4 years. MEASURES: Postal questionnaires, structured interview, extensive clinical and laboratory examinations, blood pressure (BP) changes in a postural test using different definitions for PH, history of dizziness, dizziness on testing postural blood pressure reactions (DPT), and date of death during a 4-year follow-up. RESULTS: The frequency of a fall in systolic blood pressure greater than 20 mm Hg or a fall in diastolic pressure greater than 10 mm Hg (PH-I) was 30.3%. Both criteria occurred simultaneously (PH-II) in 7.5%, and if dizziness on postural testing (DPT) was an additional symptom (PH-III), the prevalence was 2.6%. The overall prevalence of DPT was 19.7%. PH-I, PH-II, and DPT were also frequent among the healthy aged (26.6%, 6.6%, and 17.3%, respectively). The postural change in BP correlated inversely with the initial supine BP levels (systolic r = -.149, P <.001 and diastolic r = -.218, P <.001), but in persons with isolated systolic hypertension PH was rather less frequent (21.9% and 2.3%). DPT was more common in the subjects with heart failure (26.3%, P <.05), impaired exercise tolerance (NYHA III-IV) (33.7%, P <.05), and PH-II (37.2%, P <.05) compared with the healthy controls (17.3%). The 1-year mortality was higher in subjects with than without DPT (7.1% vs 4.8%, P <.05), but the difference was not significant after controlling for age and gender. PH-I, PH-II, and PH-III were nor significantly related to 4-year mortality. CONCLUSIONS: In this study of older people in Helsinki, Finland, asymptomatic hypotensive postural BP reactions and DPT were found frequently among healthy oplder people, and they tended to be increased in people with some diseases. Neither PH nor DPT were of prognostic significance for mortality in this population.
引用
收藏
页码:809 / 814
页数:6
相关论文
共 42 条
[31]  
RODSTEIN M, 1957, J Chronic Dis, V6, P581, DOI 10.1016/0021-9681(57)90012-7
[32]   ISCHEMIC HEART-DISEASE - CHEST PAIN QUESTIONNAIRE [J].
ROSE, GA .
MILBANK MEMORIAL FUND QUARTERLY-HEALTH AND SOCIETY, 1965, 43 (02) :32-39
[33]   ORTHOSTATIC HYPOTENSION IN OLDER ADULTS - THE CARDIOVASCULAR HEALTH STUDY [J].
RUTAN, GH ;
HERMANSON, B ;
BILD, DE ;
KITTNER, SJ ;
LABAW, F ;
TELL, GS .
HYPERTENSION, 1992, 19 (06) :508-519
[34]   POSTURAL DISTURBANCES IN A 75-YEAR-OLD POPULATION .1. PREVALENCE AND FUNCTIONAL CONSEQUENCES [J].
SIXT, E ;
LANDAHL, S .
AGE AND AGEING, 1987, 16 (06) :393-398
[35]   DIZZINESS IN A COMMUNITY ELDERLY POPULATION [J].
SLOANE, P ;
BLAZER, D ;
GEORGE, LK .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1989, 37 (02) :101-108
[36]   CLINICAL-SIGNIFICANCE OF A DIZZINESS HISTORY IN MEDICAL PATIENTS WITH SYNCOPE [J].
SLOANE, PD ;
LINZER, M ;
PONTINEN, M ;
DIVINE, GW .
ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (08) :1625-1628
[37]   PERSISTENT DIZZINESS IN GERIATRIC-PATIENTS [J].
SLOANE, PD ;
BALOH, RW .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1989, 37 (11) :1031-1038
[38]   POSTURAL CHANGES IN DIASTOLIC BLOOD-PRESSURE AND THE RISK OF MYOCARDIAL-INFARCTION - THE NORMATIVE AGING STUDY [J].
SPARROW, D ;
TIFFT, CP ;
ROSNER, B ;
WEISS, ST .
CIRCULATION, 1984, 70 (04) :533-537
[39]   PRIMARY ORTHOSTATIC CEREBRAL-ISCHEMIA [J].
STARK, RJ ;
WODAK, J .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1983, 46 (10) :883-891
[40]   AGING AND SUSCEPTIBILITY TO DRUG-INDUCED ORTHOSTATIC HYPOTENSION [J].
TONKIN, A ;
WING, L .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 52 (03) :277-285